$356 Million is the total value of Ghost Tree Capital, LLC's 44 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 81.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRput | $39,660,000 | +33.5% | 500,000 | +25.0% | 11.13% | -28.1% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $18,783,000 | +84.6% | 275,000 | +22.2% | 5.27% | -0.5% |
| RLMD | New | RELMADA THERAPEUTICS INCput | $18,510,000 | – | 500,000 | +100.0% | 5.20% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $18,219,000 | – | 725,000 | +100.0% | 5.11% | – |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $15,734,000 | +231.4% | 425,000 | +70.0% | 4.42% | +78.6% |
| New | AMYLYX PHARMACEUTICALS INC | $15,483,000 | – | 550,000 | +100.0% | 4.35% | – | |
| Buy | DICE THERAPEUTICS INCcall | $14,196,000 | +509.8% | 700,000 | +366.7% | 3.98% | +228.5% | |
| New | AMYLYX PHARMACEUTICALS INCput | $14,075,000 | – | 500,000 | +100.0% | 3.95% | – | |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $13,386,000 | +55.3% | 300,000 | +33.3% | 3.76% | -16.3% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $12,222,000 | +65.5% | 175,000 | +59.1% | 3.43% | -10.8% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $12,159,000 | +24.8% | 110,000 | -15.4% | 3.41% | -32.8% |
| CTIC | Buy | CTI BIOPHARMA CORP | $11,640,000 | +143.7% | 2,000,000 | +150.0% | 3.27% | +31.3% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $10,973,000 | +58.1% | 535,000 | -10.8% | 3.08% | -14.8% |
| RVNC | New | REVANCE THERAPEUTICS INC | $10,530,000 | – | 390,000 | +100.0% | 2.96% | – |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $9,810,000 | +40.7% | 95,000 | +26.7% | 2.75% | -24.2% |
| COGT | Sell | COGENT BIOSCIENCES INC | $8,952,000 | +10.3% | 600,000 | -33.3% | 2.51% | -40.6% |
| PCVX | Buy | VAXCYTE INC | $8,640,000 | +22.2% | 360,000 | +10.8% | 2.42% | -34.2% |
| ISEE | Sell | IVERIC BIO INC | $8,319,000 | +73.0% | 463,700 | -7.3% | 2.34% | -6.8% |
| SGEN | New | SEAGEN INCcall | $6,842,000 | – | 50,000 | +100.0% | 1.92% | – |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $6,748,000 | +18.5% | 30,000 | -33.3% | 1.89% | -36.1% |
| AXSM | New | AXSOME THERAPEUTICS INCcall | $6,693,000 | – | 150,000 | +100.0% | 1.88% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $6,615,000 | +92.4% | 525,000 | +61.5% | 1.86% | +3.7% |
| ALT | New | ALTIMMUNE INC | $5,555,000 | – | 435,000 | +100.0% | 1.56% | – |
| TCDA | New | TRICIDA INCcall | $5,240,000 | – | 500,000 | +100.0% | 1.47% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $5,220,000 | -51.4% | 500,000 | -50.0% | 1.46% | -73.8% |
| RETA | New | REATA PHARMACEUTICALS INCcall | $5,026,000 | – | 200,000 | +100.0% | 1.41% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $4,806,000 | +11.0% | 200,000 | -11.1% | 1.35% | -40.2% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $4,642,000 | -41.8% | 75,000 | -25.0% | 1.30% | -68.6% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $4,520,000 | +21.4% | 525,000 | +16.7% | 1.27% | -34.6% |
| New | ASTRIA THERAPEUTICS INC | $4,520,000 | – | 500,000 | +100.0% | 1.27% | – | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $4,283,000 | – | 65,000 | +100.0% | 1.20% | – |
| Buy | AADI BIOSCIENCE INC | $2,826,000 | +52.9% | 200,000 | +33.3% | 0.79% | -17.7% | |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $2,792,000 | – | 60,000 | +100.0% | 0.78% | – |
| AVTE | New | AEROVATE THERAPEUTICS INC | $2,487,000 | – | 150,000 | +100.0% | 0.70% | – |
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,328,000 | +47.8% | 300,000 | 0.0% | 0.65% | -20.4% | ||
| RAPT | Sell | RAPT THERAPEUTICS INC | $2,165,000 | -28.1% | 90,000 | -45.5% | 0.61% | -61.2% |
| TCDA | New | TRICIDA INC | $2,096,000 | – | 200,000 | +100.0% | 0.59% | – |
| TARS | TARSUS PHARMACEUTICALS INC | $2,054,000 | +17.2% | 120,000 | 0.0% | 0.58% | -36.8% | |
| DSGN | Sell | DESIGN THERAPEUTICS INC | $1,672,000 | -56.6% | 100,000 | -63.6% | 0.47% | -76.6% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $1,625,000 | – | 25,000 | +100.0% | 0.46% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $1,593,000 | – | 65,000 | +100.0% | 0.45% | – |
| ISEE | New | IVERIC BIO INCcall | $1,100,000 | – | 61,300 | +100.0% | 0.31% | – |
| BIIB | New | BIOGEN INC | $1,001,000 | – | 3,750 | +100.0% | 0.28% | – |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $526,000 | +12.6% | 1,000,000 | +8.1% | 0.15% | -39.1% |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -1,900 | -100.0% | -0.14% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.24% | – | |
| NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -1,800,000 | -100.0% | -0.24% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -50,000 | -100.0% | -1.93% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -110,000 | -100.0% | -2.41% | – |
| MRUS | Exit | MERUS N V | $0 | – | -250,000 | -100.0% | -2.95% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -35,000 | -100.0% | -3.23% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -400,000 | -100.0% | -5.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.